Constitutional Law: Race as a Factor in Interracial Adoptions

This article is part of the District of Columbia Surve

Commercial Law: Changes in Implied Warranty Disclaimers

This article is part of the District of Columbia Surve

Constitutional Law: Race as a Factor in Interracial Adoptions

This article is part of the District of Columbia Surve

CalDAG-GEFI deficiency protects mice in a novel model of FcγRIIA-mediated thrombosis and thrombocytopenia

Platelet activation via Fcγ receptor IIA (FcγRIIA) is a critical event in immune-mediated thrombocytopenia and thrombosis syndromes (ITT). We recently identified signaling by the guanine nucleotide exchange factor CalDAG-GEFI and the adenosine diphosphate receptor P2Y12 as independent pathways leading to Rap1 small GTPase activation and platelet aggregation. Here, we evaluated the contribution of CalDAG-GEFI and P2Y12 signaling to platelet activation in ITT. Mice transgenic for the human FcγRIIA (hFcR) and deficient in CalDAG-GEFI(−/−) (hFcR/CDGI(−/−)) were generated. Compared with controls, aggregation of hFcR/CDGI(−/−) platelets or P2Y12 inhibitor-treated hFcR platelets required more than 5-fold and approximately 2-fold higher concentrations of a FcγRIIA stimulating antibody against CD9, respectively. Aggregation and Rap1 activation were abolished in P2Y12 inhibitor-treated hFcR/CDGI(−/−) platelets. For in vivo studies, a novel model for antibody-induced thrombocytopenia and thrombosis was established. FcγRIIA-dependent platelet thrombosis was induced by infusion of Alexa750-labeled antibodies to glycoprotein IX (CD42a), and pulmonary thrombi were detected by near-infrared imaging technology. Anti-GPIX antibodies dose-dependently caused thrombocytopenia and pulmonary thrombosis in hFcR-transgenic but not wild-type mice. CalDAG-GEFI-deficient but not clopidogrel-treated hFcR-transgenic mice were completely protected from ITT. In summary, we established a novel mouse model for ITT, which was used to identify CalDAG-GEFI as a potential new target in the treatment of ITT

Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study.

BackgroundEnrichment strategies improve therapeutic targeting and trial efficiency, but enrichment factors for sepsis trials are lacking. We determined whether concentrations of soluble tumor necrosis factor receptor-1 (sTNFR1), interleukin-8 (IL8), and angiopoietin-2 (Ang2) could identify sepsis patients at higher mortality risk and serve as prognostic enrichment factors.MethodsIn a multicenter prospective cohort study of 400 critically ill septic patients, we derived and validated thresholds for each marker and expressed prognostic enrichment using risk differences (RD) of 30-day mortality as predictive values. We then used decision curve analysis to simulate the prognostic enrichment of each marker and compare different prognostic enrichment strategies.Measurements and main resultsAn admission sTNFR1 concentration > 8861 pg/ml identified patients with increased mortality in both the derivation (RD 21.6%) and validation (RD 17.8%) populations. Among immunocompetent patients, an IL8 concentration > 94 pg/ml identified patients with increased mortality in both the derivation (RD 17.7%) and validation (RD 27.0%) populations. An Ang2 level > 9761 pg/ml identified patients at 21.3% and 12.3% increased risk of mortality in the derivation and validation populations, respectively. Using sTNFR1 or IL8 to select high-risk patients improved clinical trial power and efficiency compared to selecting patients with septic shock. Ang2 did not outperform septic shock as an enrichment factor.ConclusionsThresholds for sTNFR1 and IL8 consistently identified sepsis patients with higher mortality risk and may have utility for prognostic enrichment in sepsis trials

Exploring Adaptive Management for Greater Sage Grouse in Northern Montana in the Face of Climate Change

A collaboration has begun in Montana among several state and federal agencies and non-governmental organizations interested in the management of greater sage grouse (Centrocercus urophasianus) in a > 5,000,000-ac (> 20,234-ha) landscape including the Charles M. Russell National Wildlife Refuge. The first step was conducting personal interviews with field biologists and managers in the general area to assess what management actions they are making. Using this information, we conducted an on-line survey to further identify those actions and how they are made. Finally, almost 40 managers and scientists met to discuss whether an adaptive management approach might be useful to gain an understanding of the interaction among habitats and management actions and how this will be affected by annual weather and climate patterns. A conceptual model of how these factors affect the life cycle of grouse has been drafted, and we are gathering comments on it. The intent is for that to be used as an ecological response model for assessing the effects of possible climate change scenarios. Future work will entail: (1) further delineation of management actions and the social networks associated with them, (2) building and evaluating a working model using rapid prototype methods, (3) conducting futures analyses of associated landscapes, (4) continuing to foster collaborative effort, and (5) working one-onone with managers to evaluate model and adaptive management applicability using such tools as LCMAP (Landscape Conservation Management and Analysis Portal)

Expression of an Arc-Immunoreactive Protein in the Adult Zebrafish Brain Increases in Response to a Novel Environment

Zebrafish are a powerful research tool in the field of neuroscience, offering several logistical and physiological advantages over rodents as a research model. However, the molecular dynamics of this model organism, especially with regards to learning and memory, are scarcely known. The current study explored the zebrafish brain for the presence of a protein bearing a similar function to the activity-regulated, cytoskeleton-associated protein (Arc), a critical player in synaptic plasticity. The adult zebrafish brain was found to express a protein with immunoreactivity against the anti-Arc antibody H-300. Immunoreactivity was detected ubiquitously, especially in areas known as adult progenitor cell zones. The protein, termed Arc-immunoreactive protein (AIP), increased in the telencephalon but not the optic tectum 60 min after exposure to a novel environment. Epileptiform brain activity, however, did not induce AIP expression. Evidence presented herein suggests AIP may be the neuropeptide Y receptor rather than a zebrafish homolog of Arc

Removing Orbital Debris with Lasers

Orbital debris in low Earth orbit (LEO) are now sufficiently dense that the use of LEO space is threatened by runaway collisional cascading. A problem predicted more than thirty years ago, the threat from debris larger than about 1 cm demands serious attention. A promising proposed solution uses a high power pulsed laser system on the Earth to make plasma jets on the objects, slowing them slightly, and causing them to re-enter and burn up in the atmosphere. In this paper, we reassess this approach in light of recent advances in low-cost, light-weight modular design for large mirrors, calculations of laser-induced orbit changes and in design of repetitive, multi-kilojoule lasers, that build on inertial fusion research. These advances now suggest that laser orbital debris removal (LODR) is the most cost-effective way to mitigate the debris problem. No other solutions have been proposed that address the whole problem of large and small debris. A LODR system will have multiple uses beyond debris removal. International cooperation will be essential for building and operating such a system.Comment: 37 pages, 15 figures, in preparation for submission to Advances in Space Researc